New eye drug aims to slow vision loss from dry macular degeneration
Disease control
Ongoing
This study tests an experimental drug called AVD-104, given as an eye injection, in 300 people with geographic atrophy (a late stage of dry age-related macular degeneration). The goal is to see if it is safe and can slow the growth of damaged areas in the retina, helping to preve…
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:53 UTC